Literature DB >> 24096772

Prevalence and topography of lymph node metastases in early esophageal and gastric cancer.

Ralf Gertler1, Hubert J Stein, Tibor Schuster, Ina-Christine Rondak, Heinz Höfler, Marcus Feith.   

Abstract

OBJECTIVE: To determine the prevalence and localization of lymph node metastases in patients with pT1 carcinoma of the esophagus, esophagogastric junction, and stomach.
BACKGROUND: Retrospective analysis and topographic description.
METHODS: We included 793 consecutive patients with pT1 carcinomas who underwent primary surgery for squamous cell carcinoma (SCC) of the esophagus, adenocarcinomas of the esophagogastric junction (AEG), or gastric cancer (GC). Clinical records and pathology reports were reviewed, and the prevalence and topography of lymph node metastases were identified.
RESULTS: The prevalence of lymph node metastases in SCC, AEG, and GC was 7%, 0%, and 5% for pT1a tumors and 24%, 18%, and 14% for pT1b tumors, respectively. Positive lymph node status was associated with worse overall survival (P<0.001). Not only infiltration of the submucosa (P=0.002) but also lymphatic vessel invasion (P<0.001), multifocal tumor growth (P=0.001), lower patient age (P=0.001), and poor tumor differentiation (P=0.05) were associated with nodal disease. These 5 parameters allowed the compilation of a nomogram to estimate the individual risk of lymph node metastases. In SCC, lymph node metastases were found from the neck to the celiac axis. In AEG, nodal disease was limited to the lower mediastinum and the D1 compartment. In GC, lymphatic spread exceeded the D1 compartment in 7% of node positive patients.
CONCLUSIONS: Risk estimation for lymph node metastases should not be based on depth of tumor infiltration alone but additional clinicopathological parameters should also be considered. The extent of lymphadenectomy in surgical procedures should respect the presented topography of lymph node metastases.

Entities:  

Mesh:

Year:  2014        PMID: 24096772     DOI: 10.1097/SLA.0000000000000239

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

Review 1.  Redefining early gastric cancer.

Authors:  Savio G Barreto; John A Windsor
Journal:  Surg Endosc       Date:  2015-04-01       Impact factor: 4.584

2.  Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma.

Authors:  Christina Oetzmann von Sochaczewski; Thomas Haist; Michael Pauthner; Markus Mann; Susanne Braun; Christian Ell; Dietmar Lorenz
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

3.  Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Jian-Kun Hu
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

Review 4.  Clinical significance of lymphadenectomy in patients with gastric cancer.

Authors:  Dezső Tóth; János Plósz; Miklós Török
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

5.  Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis.

Authors:  Shengfei Wang; Yangle Huang; Juntao Xie; Lingdun Zhuge; Longlong Shao; Jiaqing Xiang; Yawei Zhang; Yihua Sun; Hong Hu; Sufeng Chen; Toni Lerut; James D Luketich; Jie Zhang; Haiquan Chen
Journal:  Surg Endosc       Date:  2017-09-15       Impact factor: 4.584

6.  Prognostic value of the number of lymph nodes resected in patients with lymph-node-negative esophageal squamous cell carcinoma.

Authors:  Guoping Xu; Ming Jin; Yingjie Shao; Yuan Chen; Zhonghua Ning
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

Review 7.  [Differentiated surgical approach for adenocarcinoma of the gastroesophageal junction].

Authors:  W Schröder; R Lambertz; R van Hillegesberger; C Bruns
Journal:  Chirurg       Date:  2017-12       Impact factor: 0.955

Review 8.  [Surgical strategy for early stage carcinoma of the esophagus].

Authors:  N Niclauss; M Chevallay; J L Frossard; S P Mönig
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

9.  Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.

Authors:  Joshua A Boys; Stephanie G Worrell; Parakrama Chandrasoma; John G Vallone; Dipen M Maru; Lizhi Zhang; Shanda H Blackmon; Karen J Dickinson; Christy M Dunst; Wayne L Hofstetter; Michael J Lada; Brian E Louie; Daniela Molena; Thomas J Watson; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2015-09-25       Impact factor: 3.452

10.  Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens of Esophageal Adenocarcinoma: Interpretation of ER specimens.

Authors:  Stephanie G Worrell; Joshua A Boys; Parakrama Chandrasoma; John G Vallone; Christy M Dunst; Corey S Johnson; Michael J Lada; Brian E Louie; Thomas J Watson; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2015-10-26       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.